Abstract
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Endocrinology |
| Vol/bind | 150 |
| Udgave nummer | 6 |
| Sider (fra-til) | 2577-85 |
| Antal sider | 8 |
| ISSN | 0013-7227 |
| DOI | |
| Status | Udgivet - 2009 |
Bibliografisk note
Keywords: Animals; Cells, Cultured; Disease Models, Animal; Female; Glucose; Hepatocyte Nuclear Factor 1-alpha; Homeodomain Proteins; Homeostasis; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Receptors, G-Protein-Coupled; Signal Transduction; Trans-Activators; ZincAdgang til dokumentet
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
I: Endocrinology, Bind 150, Nr. 6, 2009, s. 2577-85.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction
AU - Holst, Birgitte
AU - Egerod, Kristoffer L
AU - Jin, Chunyu
AU - Petersen, Pia Steen
AU - Østergaard, Mette Viberg
AU - Hald, Jacob
AU - Sprinkel, A M Ejernaes
AU - Størling, Joachim
AU - Mandrup-Poulsen, Thomas
AU - Holst, Jens J
AU - Thams, Peter
AU - Orskov, Cathrine
AU - Wierup, Nils
AU - Sundler, Frank
AU - Madsen, Ole D
AU - Schwartz, Thue W
N1 - Keywords: Animals; Cells, Cultured; Disease Models, Animal; Female; Glucose; Hepatocyte Nuclear Factor 1-alpha; Homeodomain Proteins; Homeostasis; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Receptors, G-Protein-Coupled; Signal Transduction; Trans-Activators; Zinc
PY - 2009
Y1 - 2009
N2 - G protein-coupled receptor (GPR)-39 is a seven-transmembrane receptor expressed mainly in endocrine and metabolic tissues that acts as a Zn(++) sensor signaling mainly through the G(q) and G(12/13) pathways. The expression of GPR39 is regulated by hepatocyte nuclear factor (HNF)-1alpha and HNF-4alpha, and in the present study, we addressed the importance of GPR39 for glucose homeostasis and pancreatic islets function. The expression and localization of GPR39 were characterized in the endocrine pancreas and pancreatic cell lines. Gpr39(-/-) mice were studied in vivo, especially in respect of glucose tolerance and insulin sensitivity, and in vitro in respect of islet architecture, gene expression, and insulin secretion. Gpr39 was down-regulated on differentiation of the pluripotent pancreatic cell line AR42J cells toward the exocrine phenotype but was along with Pdx-1 strongly up-regulated on differentiation toward the endocrine phenotype. Immunohistochemistry demonstrated that GRP39 is localized selectively in the insulin-storing cells of the pancreatic islets as well as in the duct cells of the exocrine pancreas. Gpr39(-/-) mice displayed normal insulin sensitivity but moderately impaired glucose tolerance both during oral and iv glucose tolerance tests, and Gpr39(-/-) mice had decreased plasma insulin response to oral glucose. Islet architecture was normal in the Gpr39 null mice, but expression of Pdx-1 and Hnf-1alpha was reduced. Isolated, perifused islets from Gpr39 null mice secreted less insulin in response to glucose stimulation than islets from wild-type littermates. It is concluded that GPR39 is involved in the control of endocrine pancreatic function, and it is suggested that this receptor could be a novel potential target for the treatment of diabetes.
AB - G protein-coupled receptor (GPR)-39 is a seven-transmembrane receptor expressed mainly in endocrine and metabolic tissues that acts as a Zn(++) sensor signaling mainly through the G(q) and G(12/13) pathways. The expression of GPR39 is regulated by hepatocyte nuclear factor (HNF)-1alpha and HNF-4alpha, and in the present study, we addressed the importance of GPR39 for glucose homeostasis and pancreatic islets function. The expression and localization of GPR39 were characterized in the endocrine pancreas and pancreatic cell lines. Gpr39(-/-) mice were studied in vivo, especially in respect of glucose tolerance and insulin sensitivity, and in vitro in respect of islet architecture, gene expression, and insulin secretion. Gpr39 was down-regulated on differentiation of the pluripotent pancreatic cell line AR42J cells toward the exocrine phenotype but was along with Pdx-1 strongly up-regulated on differentiation toward the endocrine phenotype. Immunohistochemistry demonstrated that GRP39 is localized selectively in the insulin-storing cells of the pancreatic islets as well as in the duct cells of the exocrine pancreas. Gpr39(-/-) mice displayed normal insulin sensitivity but moderately impaired glucose tolerance both during oral and iv glucose tolerance tests, and Gpr39(-/-) mice had decreased plasma insulin response to oral glucose. Islet architecture was normal in the Gpr39 null mice, but expression of Pdx-1 and Hnf-1alpha was reduced. Isolated, perifused islets from Gpr39 null mice secreted less insulin in response to glucose stimulation than islets from wild-type littermates. It is concluded that GPR39 is involved in the control of endocrine pancreatic function, and it is suggested that this receptor could be a novel potential target for the treatment of diabetes.
U2 - 10.1210/en.2008-1250
DO - 10.1210/en.2008-1250
M3 - Journal article
C2 - 19213833
SN - 0013-7227
VL - 150
SP - 2577
EP - 2585
JO - Endocrinology
JF - Endocrinology
IS - 6
ER -